Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout

Current Medical Research and Opinion

Volumn 23, Issue 7, 2007, Pages 1685-1691

  Navarra, Sandra ^a   Rubin, Bernard R ^b   Yu, Qinfen ^c   Smugar, Steven S ^c   Tershakovec, Andrew M ^c  

^a UNIVERSITY OF SANTO TOMAS   (Philippines)

^b UNIVERSITY OF NORTH TEXAS   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Efficacy; Etoricoxib; Gout; Indomethacin; Response

Indexed keywords

ALLOPURINOL; COLCHICINE; ETORICOXIB; INDOMETACIN;

ADULT; ANALYSIS OF COVARIANCE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

ACUTE DISEASE; ADULT; ARTHRALGIA; ARTHRITIS; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FEMALE; GOUT; GOUT SUPPRESSANTS; HUMANS; INDOMETHACIN; MALE; MIDDLE AGED; PYRIDINES; SULFONES;

EID: 34547214873     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X210750     Document Type: Conference Paper

References (27)

1. Roubenoff R. Gout and hyperuricemia. Rheum Dis Clin North Am 1990;16:539-50
2. Schumacher HR. Crystal-induced arthritis: an overview. Am J Med 1996;100:46S-52S
3. Terkeltaub RA, Ginsberg MH. The inflammatory reaction to crystals. Rheum Dis Clin North Am 1988;14:353-64
4. Harris MD, Siegel LB, Alloway JA. Gout and hyperuricemia. Am Fam Physician 1999;59:925-34
5. Schlesinger N. Management of acute and chronic gouty arthritis: present state-of-the-art. Drugs 2004;64:2399-416
6. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002;40:37-42
7. Mikuls TR, Saag KG. New insights into gout epidemiology. Curr Opin Rheumatol 2006;18:199-203
8. Mikuls TR, Farrar JT, Bilker WB, et al. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-72
9. Wortmann RL. Gout and hyperuricemia. Curr Opin Rheumatol 2002;14:281-6
10. Terkeltaub RA. Clinical practice. Gout. New Engl J Med 2003;349:1647-55
11. Rott KT, Agudelo CA. Gout. J Am Med Assoc 2003;289: 2857-60
12. Smyth CJ, Percy JS. Comparison of indomethacin and phenylbutazone in acute gout. Ann Rheum Dis 1973;32:351-3
13. Ruotsi A, Vainio U. Treatment of acute gouty arthritis with proquazone and indomethacin. A comparative, double-blind trial. Scand J Rheumatol Suppl 1978;21:15-7
14. Fraser RC, Davis RH, Walker FS. Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia. J R Coll Gen Pract 1987;37:409-11
15. Altman RD, Honig S, Levin JM, et al. Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study. J Rheumatol 1988;15: 1422-6
16. Alloway JA, Moriarty MJ, Hoogland YT, et al. Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis. J Rheumatol 1993;20:111-3
17. Rubin BR, Burton R, Navarra S, et al. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. Arthritis Rheum 2004;50: 598-606
18. Schumacher Jr HR, Boice JA, Daikh DI, et al. Randomised double blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis. Br Med J 2002;324:1488-92
19. Pittman JR, Bross MH. Diagnosis and management of gout. Am Fam Physician 1999;59:1799-806, 10
20. Lawry 2nd GV, Fan PT, Bluestone R. Polyarticular versus monoarticular gout: a prospective, comparative analysis of clinical features. Medicine (Baltimore) 1988;67:335-43
21. Hadler NM, Franck WA, Bress NM. Acute polyarticular gout. Am J Med 1974;56:715-9
22. Kim KY, Schumacher HR, Hunsche E, et al. A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003;25:1593-617
23. Groff GD, Franck WA, Raddatz DA. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum 1990;19:329-36
24. Turk DC, Rudy TE. Neglected factors in chronic pain treatment outcome studies - referral patterns, failure to enter treatment, and attrition. Pain 1990;43:7-25
25. Whitney CW, Von Korff M. Regression to the mean in treated versus untreated chronic pain. Pain 1992;50:281-5
26. Lin HM, Hughes MD. Adjusting for regression toward the mean when variables are normally distributed. Stat Methods Med Res 1997;6:129-46
27. Rechziegler H, Zündorf P. Acemetacin in the treatment of rheumatic diseases: an open, multicentre trial. Curr Med Res Opin 1985;9:701-7